Primary Immune Thrombocytopenia and Thrombopoietin Receptor Agonists: Feasibilities of Treatment Discontinuation upon Achieving Stable Complete Platelet Response

Aim. To assess the stability of clinical remission in patients with primary immune thrombocytopenia (ITP) after withdrawal of thrombopoietin receptor agonists (TPO-RAs). Materials & Methods. The study enrolled 456 patients with primary ITP who received second- and subsequent-line TPO-RA treatment...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	O. Yu. Vinogradova, M. M. Pankrashkina, Anna Leonidovna Neverova, M. V. Chernikov, L. A. Mukha, D. I. Shikhbabaeva, V. V. Ptushkin
Μορφή:	Artigo
Γλώσσα:	Russo
Έκδοση:	Practical Medicine Publishing House 2023-09-01
Σειρά:	Клиническая онкогематология
Θέματα:	primary immune thrombocytopenia itp thrombopoietin receptor agonists romiplostim eltrombopag
Διαθέσιμο Online:	https://bloodjournal.ru/index.php/coh/article/view/54
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!